Hologic Hits New 52-Week High Following Better-Than-Expected Earnings (HOLX)
Hologic (NASDAQ:HOLX) shares hit a new 52-week high on Wednesday following a better than expected earnings announcement, StockRatingsNetwork.com reports. The company traded as high as $26.35 and last traded at $25.98, with a volume of 2,000,571 shares. The stock had previously closed at $25.53.
The company reported $0.37 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.34 by $0.03. The company had revenue of $632.60 million for the quarter, compared to the consensus estimate of $621.89 million. During the same quarter last year, the company posted $0.38 earnings per share. Hologic’s revenue was up 1.0% compared to the same quarter last year.
A number of analysts have recently weighed in on HOLX shares. Analysts at ISI Group raised their price target on shares of Hologic from $27.00 to $29.00 in a research note on Wednesday, July 9th. Separately, analysts at BTIG Research downgraded shares of Hologic from a “buy” rating to a “neutral” rating in a research note on Monday, July 7th. Finally, analysts at Standpoint Research downgraded shares of Hologic from a “buy” rating to a “hold” rating in a research note on Wednesday, July 2nd. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $24.13.
The stock’s 50-day moving average is $25.36 and its 200-day moving average is $22.95. The company’s market cap is $7.173 billion.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.